Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.

Overexpressed galectin-3 in pancreatic cancer induces cell proliferation and invasion by binding Ras and activating Ras signaling.
复制标题

胰腺癌中过表达的乳肠蛋白3通过结合Ras并激活RAS信号传导诱导细胞增殖和侵袭。

DOI:
10.1371/journal.pone.0042699
复制
发表时间:
2012
期刊:
影响因子:
3.7
通讯作者:
Bresalier RS
Bresalier RS
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Song S;Ji B;Ramachandran V;Wang H;Hafley M;Logsdon C;Bresalier RS

文献摘要

参考文献

被引文献

相似文献

胰腺癌(PDAC)是一种致命的疾病,5年生存率为3-5%。K-Ras突变几乎在所有病例中都有发现,但K-Ras突变本身并不足以导致PDAC的发展。其他因素有助于Ras信号的激活并导致肿瘤的形成。半乳糖凝集素-3 (Gal-3)是一种多功能β-半乳糖苷结合蛋白,在PDAC中高表达。因此,我们研究了Gal-3在胰腺癌进展中的功能作用及其与Ras信号的关系。采用免疫组织化学、Q-PCR和免疫印迹法检测Gal-3的表达。功能研究使用基因工程胰腺细胞系表达高或低水平的Gal-3。采用Raf下拉法检测Ras活性。免疫共沉淀法和免疫荧光法用于评估蛋白相互作用。在这项研究中,我们证明了Gal-3在人类肿瘤和突变的K-Ras小鼠PDAC模型中被高度上调。慢病毒shRNA下调Gal-3可降低PDAC细胞的体外增殖和侵袭,减少原位小鼠模型中肿瘤的体积和大小。Gal-3结合Ras并维持Ras活性;Gal-3的下调降低了Ras活性以及Ras下游信号传导,包括ERK和AKT的磷酸化以及Ral A活性。转染Gal-3 cDNA到低水平Gal-3增强Ras活性及其下游信号传导的PDAC细胞。这些结果表明,在一定程度上,Gal-3通过结合Ras和激活Ras信号通路促进了胰腺癌的进展。因此,Gal-3可能是这种致命疾病的潜在新靶点。
Pancreatic cancer (PDAC) is a lethal disease with a five-year survival of 3–5%. Mutations in K-Ras are found in nearly all cases, but K-Ras mutations alone are not sufficient for the development of PDAC. Additional factors contribute to activation of Ras signaling and lead to tumor formation. Galectin-3 (Gal-3), a multifunctional β-galactoside-binding protein, is highly expressed in PDAC. We therefore investigated the functional role of Gal-3 in pancreatic cancer progression and its relationship to Ras signaling. Expression of Gal-3 was determined by immunohistochemistry, Q-PCR and immunoblot. Functional studies were performed using pancreatic cell lines genetically engineered to express high or low levels of Gal-3. Ras activity was examined by Raf pull-down assays. Co-immunoprecipitation and immunofluorescence were used to assess protein-protein interactions. In this study, we demonstrate that Gal-3 was highly up-regulated in human tumors and in a mutant K-Ras mouse model of PDAC. Down-regulation of Gal-3 by lentivirus shRNA decreased PDAC cell proliferation and invasion in vitro and reduced tumor volume and size in an orthotopic mouse model. Gal-3 bound Ras and maintained Ras activity; down-regulation of Gal-3 decreased Ras activity as well as Ras down-stream signaling including phosphorylation of ERK and AKT and Ral A activity. Transfection of Gal-3 cDNA into PDAC cells with low-level Gal-3 augmented Ras activity and its down-stream signaling. These results suggest that Gal-3 contributes to pancreatic cancer progression, in part, by binding Ras and activating Ras signaling. Gal-3 may therefore be a potential novel target for this deadly disease.
DOI: 10.1038/modpathol.3800460
发表时间: 2005-11-01
期刊: MODERN PATHOLOGY
影响因子: 7.5
作者:
Khayyata, S;Basturk, O;Adsay, NV
通讯作者: Adsay, NV
DOI: 10.1158/0008-5472.can-05-0775
发表时间: 2005-08-15
期刊: CANCER RESEARCH
影响因子: 11.2
作者:
Shalom-Feuerstein, R;Cooks, T;Kloog, Y
通讯作者: Kloog, Y
DOI: 10.1097/00006676-200404000-00008
发表时间: 2004-04-01
期刊: PANCREAS
影响因子: 2.9
作者:
Takaori, K;Hruban, RH;Tanigawa, N
通讯作者: Tanigawa, N
DOI: 10.1074/jbc.m312697200
发表时间: 2004-08-13
影响因子: 4.8
作者:
Elad-Sfadia, G;Haklai, R;Kloog, Y
通讯作者: Kloog, Y
前梯度2在胰腺癌的发展过程中表达和分泌,并促进癌细胞的存活。
DOI: 10.1158/0008-5472.can-08-1320
发表时间: 2008-10-01
期刊: Cancer research
影响因子: 11.2
作者:
Ramachandran V;Arumugam T;Wang H;Logsdon CD
通讯作者: Logsdon CD